Holen Sie sich die Stockscreener-App
1.88
3.59%
0.07
Schlusskurs vom Vortag:
$1.81
Offen:
$1.87
24-Stunden-Volumen:
284.04K
Relative Volume:
0.54
Marktkapitalisierung:
$83.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.46%
1M Leistung:
-15.16%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.84
$1.91
1-Wochen-Bereich:
$1.80
$2.19
52-Wochen-Spanne:
$1.42
$2.30
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Firmenname
Mindwalk Holdings Corp
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie HYFT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HYFT
Mindwalk Holdings Corp
|
1.87 | 83.54M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.07 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.04 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.61 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.47 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.09 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-25 | Eingeleitet | The Benchmark Company | Buy |
Mindwalk Holdings Corp Aktie (HYFT) Neueste Nachrichten
MindWalk (HYFT) Announces Share Repurchase Plan - GuruFocus
MindWalk Holdings (HYFT) Announces 2.3M Share Buyback Program - GuruFocus
MindWalk Holdings Corp. authorizes a Buyback Plan. - MarketScreener
MindWalk Holdings Corp. announces an Equity Buyback for 2,300,000 shares. - MarketScreener
MindWalk Holdings announces 2.3M share buyback program - MSN
MindWalk announces $2.3 million share repurchase program By Investing.com - Investing.com Nigeria
MindWalk Holdings Initiates Share Repurchase Program to Enhance Shareholder Value - TipRanks
MindWalk announces $2.3 million share repurchase program - Investing.com India
MindWalk Announces Share Repurchase Program - The Joplin Globe
MindWalk Unveils Dual-Pathway Regimen in Longevity Therapeutics - MSN
MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand - Insider Monkey
MindWalk expands GLP-1 program with AI-discovered longevity pathway By Investing.com - Investing.com Nigeria
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity - The AI Journal
Accelerating Drug Discovery through First End-to-End Bio-Native AI Platform (09/22/2025 00:00 - MarketScreener
MindWalk stock soars on dual-pathway GLP-1 therapeutic advancement By Investing.com - Investing.com South Africa
MindWalk stock soars on dual-pathway GLP-1 therapeutic advancement - Investing.com
MindWalk (HYFT) Unveils Breakthrough in GLP-1 Therapeutic Progra - GuruFocus
MindWalk expands GLP-1 program with AI-discovered longevity pathway - Investing.com
MindWalk advances AI-designed GLP-1 program with first-in-class dual-pathway regimen for aging and longevity - MarketScreener
MindWalk : Accelerating Drug Discovery through First End-to-End Bio-Native AI Platform - MarketScreener
How MindWalk Holdings' Rebranding and Improved Earnings May Impact HYFT Investors - Yahoo Finance
MindWalk Holdings Reports Strong Revenue Growth and Improved Margins - TipRanks
MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic ... - Yahoo Finance
MindWalk Holdings Corp (HYFT) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Rebranding - GuruFocus
MindWalk Holdings Reports Q3 2025 Financial Results and Strategic Growth - TipRanks
MindWalk Holdings Corp reports results for the quarter ended July 31Earnings Summary - TradingView
MindWalk Holdings Corp. Reports Earnings Results for the First Quarter Ended July 31, 2025 - MarketScreener
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly - PharmiWeb.com
Earnings call transcript: MindWalk Inc. reports strong Q1 2025 performance, rebrands from ImmunoPrecise Antibodies - Investing.com UK
MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet - Business Wire
MindWalk Holdings Reports Record Revenue and Strategic Divestiture - TipRanks
MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet | FinancialContent - FinancialContent
MindWalk : 2025 Combined Financial Statements - MarketScreener
MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025 - Business Wire
MindWalk Holdings Corp.HYFTStock Price Today - Zacks Investment Research
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView
ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT By Investing.com - Investing.com Canada
HYFT's Rebranding: A Strategic Pivot in Biotech's AI-Driven Future - AInvest
ImmunoPrecise Antibodies rebrands as MindWalk, changes ticker to HYFT - Investing.com
Immunoprecise rebrands as Mindwalk, announces Nasdaq ticker change to "HYFT" - MarketScreener
ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT” - FinancialContent
Leading Biotech ImmunoPrecise Antibodies Joins Major H.C. Wainwright Investment Conference in New York - Stock Titan
AI-Powered Universal Dengue Vaccine Breakthrough: ImmunoPrecise's LENSai Platform Advances to Animal Studies - Stock Titan
Strategic Acquisition: AVS Bio Expands Global Biologics Reach with ImmunoPrecise Europe Buyout - Stock Titan
ImmunoPrecise Antibodies (IPA) Reports Full Fiscal Year 2025 Results, Record Fourth Quarter Revenue, and Record Fourth Quarter Adjusted EBITDA - Business Wire
Finanzdaten der Mindwalk Holdings Corp-Aktie (HYFT)
Es liegen keine Finanzdaten für Mindwalk Holdings Corp (HYFT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):